Furthermore, the Aurora B inhibitor enhanced IGF1R inhibitor-induced suppression of cell proliferation, suggesting a potential for simultaneous use of IGF1R and Aurora B inhibitors in novel approaches to cancer chemotherapy. The gene discussed is AURKB; the disease is cancer.